Active Ingredient(s):Zoledronic Acid FDA Approved: * August 20, 2001 Pharm Company: *NOVARTIS Category:Cancer
Zoledronic acid, also known as zoledronate and sold under the brand name Zometa by Novartis among others, is a medication used to treat a number of bone diseases. These include osteoporosis, high blood calcium due to cancer, bone breakdown due to cancer, Paget’s disease of bone and Duchenne muscular dystrophy (DMD). It is given by injection into a vein.
Common side effects include fever, joint pain, high blood ...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion